European Peptide Synthesis Conference 2025

Register for the event

This event has passed.

European Peptide Synthesis Conference 2025

This event will bring together the peptide community for three days of stimulating talks discussing the latest technologies and research for the entire workflow of synthetic production of peptides.

Throughout the three-day conference, the following topics will be covered:

  • Latest Synthetic Strategies
  • Approaches for High-Throughput Peptide Synthesis
  • Synthetic Production of Proteins
  • Peptide Analysis & Purification
  • cGMP Peptide Synthesis
  • Peptide Applications

 

Bachem is participating in this event. Join our Bachem Presentations; See below for more Information.

See who is attending from Bachem

Daniel Yasini

Sales Manager Custom Synthesis

See who is presenting on-site

Peptide Synthesis by Molecular Hiving

August 26, 2025, 1:30 - 2:00 PM, Conference Room

The 3rd wave is large and green: Bachem’s scale-up of tag-assisted liquid-phase peptide manufacturing to meet the rising market demand

SPEAKER

Ralph Schönleber

Vice President R&D

Ralph Schönleber is a chemist by training, with a PhD in organic chemistry from the University of Basel, studying coumarins as photoactive protecting groups. Ralph joined Bachem AG in 2003 as a team leader at the Research and Development Department. After increasing responsibilities in the fields of process development (scale-up strategies for all amounts of peptide products), process research and synthesis of custom and catalog products, he became Head of the GMP Process Development Department in 2012. Currently, Ralph is Vice President Research and Development at Bachem AG and member of Bachem’s International Research Committee.

Greener peptide purification using sample displacement chromatography

August 26, 2025, 4:00 - 4:15 PM, Conference Room

Sample displacement chromatography (SDC) is normally associated with purification of macromolecules but has been employed for peptide purification for many decades. The technique involves overloading of a sample mixture onto a purification column, exploiting differences in affinity of the product/impurity mixture for the stationary phase. As the sample is loaded, the species with high affinity displace those with a lower affinity for the media as the components compete for available binding sites, thus separating the mixture. However, as SDC is low pressure, it typically results in enriched bands of products, rather than sharp baseline resolved peaks.

SDC was superseded by the invention of technology that allowed scale up of high-pressure chromatographic (HPLC) methods, giving higher fraction purity by improved product resolution. However, recent advances in the quality of media for low pressure purification (flash) has enabled SDC of peptides to be revived as a complementary method to HPLC.

SDC is optimally performed in highly overloading conditions and utilizes the full binding site capacity of the media. Therefore, the advantage of the SDC technique over reverse phase prep HPLC is high throughput with lower material costs, lower waste and lower hardware costs. This allows for accessible scale up using simple labware, such as cartridge columns, flash LC systems and peristaltic pumps.

We will show that SDC can be used to purify short to medium length peptides (~10-25 AA) to a high purity using benchtop hardware, with a significant reduction in solvent use and waste. We will also demonstrate our ability to predict the capacity and product distribution throughout the purification media.

SPEAKER

Gavin Noble

Director of Production

Gavin is serving as Director of Production at Bachem UK since 2023 and has been working at Bachem for 11 years, including 9 years as Process Optimisation Chemist and spent few months at Bachem Bubendorf as part of a know-how exchange program, working in the R&D Team as Project Chemist.

Prior to his time at Bachem, Gavin earned his PhD from The University of Manchester (UK), performing research into protein and enzyme activity at synthetic liposome surfaces and spent 2 years as post-doctoral fellow at The University of Notre Dame (USA), researching peptide-targeted liposome nanoparticles for cancer and antimalarial therapies.

Upcoming Events